Charles Dadswell is stepping down after more than a decade at the legal helm of gene sequencing giant Illumina, the company announced in a late Thursday securities filing.

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the world, and I'm proud to have been a part of that journey," Dadswell said in a statement.